We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Justice Joins Suit Against Abbott Over Depakote Off-Label Uses
Justice Joins Suit Against Abbott Over Depakote Off-Label Uses
February 4, 2011
The Department of Justice has intervened in a whistle-blower lawsuit accusing Abbott Laboratories of knowingly marketing its antipsychotic Depakote for off-label uses and providing kickbacks to doctors to prescribe the drugs.